Acute and chronic treatment with 5-HT reuptake inhibitors differentially modulate emotional responses in anxiety models in rodents

Psychopharmacology

Volumn 113, Issue 3-4, 1994, Pages 463-470

  Griebel, Guy ^a   Moreau, Jean Luc ^b   Jenck, François ^b   Misslin, René ^a   Martin, James R ^b  

^a Laboratoire de Psychophysiologie   (France)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

5 HT reuptake inhibitors; Acute and chronic treatments; Anxiety; Cianopramine; Citalopram; Elevated plus maze test; Light dark choice procedure; Neophobia

Indexed keywords

CIANOPRAMINE; CITALOPRAM; SEROTONIN UPTAKE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DARKNESS; EMOTION; EXPLORATORY BEHAVIOR; INTRAPERITONEAL DRUG ADMINISTRATION; LIGHT; LOCOMOTION; MALE; MAZE TEST; MOUSE; NEOPHOBIA; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM;

ANIMAL; ANXIETY; CITALOPRAM; EMOTIONS; EQUILIBRIUM; EXPLORATORY BEHAVIOR; IMIPRAMINE; MALE; MICE; MOTOR ACTIVITY; PSYCHOMOTOR PERFORMANCE; RATS; RATS, WISTAR; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS;

EID: 0028224702     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/BF02245224     Document Type: Article

References (39)

1. Differential effects of clomipramine given locally or systematically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. An in vivo brain microdialysis study
2. Therapeutic effects of serotonin uptake inhibitors in depression
3. Anxiogenic effects of methyl-β-carboline in a light/dark choice situation
4. The effects of chronic antidepressant treatment in an animal model of anxiety
5. A comparison of the effects of diazepam versus several typical and atypical antidepressant drugs in an animal model of anxiety
6. Presynaptic and postsynaptic modifications of the serotonin system by long-term administration of antidepressant treatments. An in vivo electrophysiologic study in the rat
7. Animal models of anxiety: the effects of compounds that modify 5-HT neurotransmission
8. Animal models for predicting clinical efficacy of anxiolytic drugs: social behaviour
9. Interaction between effects of caffeine and lorazepam in performance tests and self-ratings
10. Effects of acute and chronic anti-panic drug administration on conflict behavior in the rat
11. Overcoming hypersensitivity to fluoxetine in a patient with panic disorder
12. Evidence for abnormal serotonergic function in obsessive compulsive disorder
13. An open trial of fluoxetine in the treatment of panic attacks
14. Serenics fluprazine (DU 27716) and eltoprazine (DU 28853) enhance neophobic and emotional behaviour in mice
15. m — Chlorophenylpiperazine enhances neophobic and anxious behaviour in mice
16. Anxiolytic-like effects of a selective 5-HT1A agonist, S20244, and its enantiomers in mice
17. Serotonin and anxiety: an open study of citalopram in panic disorder
18. Neurochemical characterization of a new potent and selective serotonin uptake inhibitor: Lu 10-171
19. Obsessive-compulsive disorder and serotonin: is there a connection?
20. Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex
21. Interactions of serotonin with ethanol: clinical and animal studies
22. Amine uptake inhibitors: criteria of selectivity
23. 5-HT uptake inhibitors: psychopharmacological and neurobiochemical criteria of selectivity
24. Effects of sertraline and citalopram given repeatedly on the responsiveness of 5-HT receptor subpopulations
25. Clinical significance of 5-HT uptake inhibitors
26. Is Ro 11-2465 (cyanimipramine) an antagonist of postsynaptic serotonin receptors?
27. Ro 11-2465 (cyan-imipramine), citalopram and their N-desmethyl metabolites: effects on the uptake of 5-hydroxytryptamine and noradrenaline in vivo and related pharmacological activities
28. Anxiolytic and anxiogenic drug effects in a novel test of anxiety: are exploratory models of anxiety in rodents valid?
29. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat
30. Selective agonists and antagonists for 5-hydroxytryptamine receptor subtypes, and interactions with yohimbine and FG 7142 using the elevated plus-maze test in the rat
31. Behavioral differences in an elevated plus-maze: correlation between anxiety and decreased number of GABA and benzodiazepine receptors in mouse cerebral cortex
32. Classification and determination of cerebral bioavailability of fluoxetine: pharmacokinetic, pharmaco-EEG and psychometric analyses
33. Anxiolytic effects of benzodiazepines and 5-HT1A agonists: animal models
34. Serotonin disturbances in psychiatric disorders: functional versus nosological interpretation
35. Clinical and biochemical effects of selective serotonin-uptake inhibitors in anxiety disorders